ProCE Banner Activity

LUMINA: Local Recurrence With Omission of Radiotherapy After Breast-Conserving Surgery in T1N0 Luminal A Breast Cancer

Slideset Download
Conference Coverage
Women with clinically favorable low-risk breast cancer demonstrated a 5-year rate of local recurrence of less than 5% after breast-conserving survey and endocrine therapy without radiotherapy.

Released: June 15, 2022

Begin Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

BMS

Daiichi Sankyo Inc

Gilead Sciences, Inc.

GlaxoSmithKline

Jazz Pharmaceuticals Inc

Merck Sharp & Dohme Corp

Novartis Pharmaceuticals Corporation

Seagen and Genmab